Drug
Odm 201
Odm 201: highest development phase Phase 1/2, developed by Orion Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| ODM-201 NCT01317641 | Phase 1/2 | Prostate Cancer |
Latest
No recent events.
Follow Odm 201 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.